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for	 trisomies	21,	18,	and	13	 is	offered	 to	all	pregnant	women	 in	 the	Netherlands.	
NIPT	using	genome	sequencing	allows	for	an	expansion	of	the	scope	of	FTS	and	the	









had	already	deliberated	about	what	an	abnormal	 test	 result	would	mean	 to	 them.	
Others	accepted	or	declined	FTS	without	deliberation.	The	current	Dutch	policy	of	
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mon	 aneuploidies,	 pregnant	 women	 could	 choose	 either	 invasive	
prenatal	 genetic	 testing	or	 refrained	 from	 further	 testing	 (Oepkes	
et	al.,	2016;	Taylor,	Chock,	&	Hudgins,	2014).	On	the	April	1,	2014,	
the	possibility	 to	opt	 for	 the	noninvasive	prenatal	 test	 (NIPT)	 in	 a	
national	implementation	study	‘trial	by	Dutch	laboratories	for	evalu‐
ation	of	non‐invasive	prenatal	testing’	(TRIDENT‐1)	was	added.
Since	 April	 1,	 2017,	 all	 pregnant	 women	 in	 the	 Netherlands	
have	a	choice	between	no	first	trimester	screening	(FTS),	the	ftCT,	

































Second,	 there	 are	 concerns	 about	 the	 influence	 of	 reimburse‐
ment	 policies	 on	 pregnant	 couples’	 views	 and	 uptake	 of	 prenatal	
screening.	 Pregnant	 couples	might	 easily	 or	 thoughtlessly	 opt	 for	
reimbursed	screening,	whereas	nonreimbursed	screening	may	lead	











Third,	 whole	 genome	 NIPT	 can	 detect	 a	 wide	 range	 of	 fetal	
chromosome	abnormalities	 in	addition	 to	 trisomies	21,	18,	and	13	
(Morain,	Greene,	&	Mello,	2013).	At	the	moment,	pregnant	women	
in	 the	Netherlands	 can	 choose	 for	 a	NIPT	 that	 only	 reveals	 triso‐
mies	 21,	 18,	 and	 13,	 or	 a	 NIPT	 that	 also	 reveals	 abnormalities	 in	
other	 chromosomes,	 indicated	 as	 secondary	 findings.	However,	 in	
the	Netherlands	 fetal	 sex	 and	 sex	 chromosomal	 abnormalities	 are	
not	 communicated,	 because	 the	ministerial	 license	does	not	 allow	
analysis	of	 the	sex	chromosomes	 (Oepkes	et	al.,	2016).	Expanding	







people	 fear	 that	with	an	expansion	of	 the	 scope,	prenatal	 screen‐
ing	 is	 on	 a	 ‘slippery‐slope’	 towards	 screening	 for	minor	 abnormal‐




started	 in	many	clinics	 in	many	developed	countries,	 including	the	
United	States	and	the	Netherlands	(Oepkes	et	al.,	2016;	Wapner	et	
al.,	 2015).	 An	 expanded	NIPT	 includes	 other	 trisomies	 in	 addition	
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and	an	expanded	scope	of	NIPT.	 Interviews	with	pregnant	women	













For	 this	 study	a	qualitative	 research	design	was	used.	 Semi‐struc‐
tured	 individual	 interviews	 were	 held	 to	 explore	 the	 experiences	
and	 opinions	 of	 pregnant	 women	 regarding	 first	 trimester	 pre‐
natal	 screening	 and	 in	 particular	 NIPT.	 Ten	 interviews	 were	 con‐
ducted	before	the	availability	of	NIPT	to	all	pregnant	women	in	the	











practices	 across	 the	 country.	 The	 researchers	 deliberately	 sought	
to	include	women	with	different	ethnic	and	religious	backgrounds,	
educational	 levels,	 and	 socioeconomic	 status.	 However,	 women	
who	 signed	 up	 for	 the	 study	were	mostly	 Caucasian,	 highly	 edu‐
cated	women.	Women	were	 interviewed	 throughout	 all	 phases	of	
their	pregnancy.	All	19	women	were	offered	first	trimester	prenatal	
screening;	11	of	them	opted	for	prenatal	screening	(NIPT	or	ftCT),	
whereas	 eight	 did	 not.	 None	 of	 the	 pregnant	 women	 who	 chose	



















pregnancy.	 Furthermore,	 we	 included	 questions	 about	 the	 reim‐









pared	 and	 any	 discrepancies	 were	 discussed	 until	 consensus	 was	

























4  |     BAKKEREN Et Al.
3  | RESULTS

























gave	 various	 reasons.	 Some	 chose	 screening	 because	 they	 wanted	








compared	 to	 the	 ftCT,	make	 testing	more	attractive	 to	women.	Ten	
women	were	interviewed	before	NIPT	became	available	as	a	first‐tier	
test	 in	 the	 Netherlands.	Most	 of	 these	 women	 indicated	 that	 they	
would	have	opted	 for	NIPT	 if	 it	was	 available	 for	 them	during	 their	
pregnancy.	The	 interviewed	women	expected	an	 increase	 in	uptake	







because	 it	 is	 easier	 and	 more	 accessible	 (…).	 That	














Therefore,	 pretest	 counseling	 for	 FTS	 should	 emphasize	 choice	
awareness	 among	 pregnant	 women.	 According	 to	 the	 interviewed	





test	 result.	However,	 other	women	 indicated	 that	 they	 did	 not	 think	
about	what	to	do	with	the	test	result	before	engaging	in	prenatal	screen‐
ing.	They	first	wanted	to	wait	and	see	what	the	test	result	would	be.
















A	 few	 younger	women	 (age	 range:	 24–30)	 in	 our	 sample	 ex‐
pected	influence	from	family	or	friends	on	their	choice	when	they	
would	 be	 older,	 because	 then	 they	 would	 be	 at	 higher	 risk	 and	
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Nobody said	 [during	 the	counseling	session]:	you can 
also do nothing.	(I11,	age	40,	NIPT)
A	 few	 women	 believed	 that	 society	 participation	 in	 prenatal	
screening	 is	 portrayed	 as	 being	 self‐evident	 amongst	 others	 caused	




























nancy;	 there	 are	 different	 opinions,	 influenced	 by,	 amongst	 others,	
culture	and	religious	beliefs.






for	 screening.	They	expected	 to	be	 influenced	by	 the	price	of	 the	
test,	and	probably	would	not	opt	 for	 it	 if	 it	were	expensive.	Some	
thought	 that	 if	 the	 tests	were	 free	of	charge	 they	would	certainly	



















I	do	not	know,	if	 it	 is	completely	reimbursed	it	 is	ac‐











People	differ	 in	 their	 incomes	and	then	 [by	asking	a	




3.4 | Expansion of the scope of prenatal screening
The	discussion	on	 the	expanding	 scope	of	prenatal	 screening	was	
often	difficult	 to	understand	 for	women.	When	asked	about	 their	
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preferences,	 benefits,	 and	 disadvantages	 of	 an	 expanded	 scope,	
women	found	it	difficult	to	formulate	their	opinions	because	of	lack	
of	knowledge.














Just	 in	 general,	 I	 am	 opposed	 to	 everything	 being	
placed	in	a	medical	framework.	That	you	can	already	
know	so	many	things	in	advance	[before	the	baby	is	
born].	 The	 question	 is	 of	 course	where	 this	 [expan‐




tal	 screening	 is	positive,	because	 it	provides	certainty,	or	 they	were	
in	favor	of	an	expansion	because	it	might	prevent	a	long	search	for	a	
diagnosis	when	a	child	is	born	with	unexplained	symptoms.
I	 would	 appreciate	 it	 when	 the	 test	 becomes	 ex‐
panded.	 I	 think	 it	 is	 something	 good	because	 it	 just	














concern	 severely	 disabled	 children.	 Children	 who	
could	 never	 live	 independently,	 who	 need	 a	 lot	 of	
medical	care,	where	you	ask	yourself	if	they	could	be	
happy	at	all.	(I11,	age	40,	NIPT)




































their	 obstetric	 caregiver,	whereas	others	made	 this	 choice	 after	
counseling.	Most	 women	 indicated	 that	 counseling	 for	 first	 tri‐








beforehand,	 which	 is	 also	 underlined	 by	 healthcare	 professionals.	
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Deliberation,	defined	as	the	weighing	and	considering	of	what	pro‐
spective	parents	consider	to	be	a	worthy	life	for	their	child	and	what	







previous	 studies,	 although	one	 study	did	 find	 that	 not	wanting	 to	
think	about	what	to	do	with	a	possible	abnormal	test	result	can	be	
a	reason	for	pregnant	women	to	decline	prenatal	screening	(Garcia,	
Timmermans,	&	van	Leeuwen,	2008a).	 This	 discrepancy	gives	 rise	
to	the	question	what	should	be	the	focus	of	the	prenatal	screening	
counseling.Currently,	 the	main	 focus	 of	 pretest	 counseling	 is	 pro‐
viding	information	(Martin	et	al.,	2014),	but	our	results	suggest	that	











































to	 (not)	 engage	 in	 prenatal	 screening,	 however,	 some	of	 them	did	
express	the	concerns	that	in	society	there	are	certain	expectations	
with	regard	to	participation	 in	screening	and	either	 termination	of	







views	 could	 be	 explained	 by	 differences	 in	 test	 choice,	 personal	
(financial)	situation,	and	other	aspects.	Pregnant	women	did	agree	




be	 seen	with	 the	 second	 trimester	 sonography	scan,	of	which	 the	
uptake	is	over	90%	in	the	Netherlands	(Liefers,	Cruijsberg,	&	Atsma,	
2017).	 Pregnant	women	believed	 that	 by	 reimbursing	 first	 trimes‐
ter	 screening,	 the	 uptake	will	 increase	 and	women	might	 venture	
into	 prenatal	 screening	 less	 thoughtfully.	 Some	 women	 indicated	
that	asking	a	 (small)	 fee	made	them	think	about	their	choice.	They	
believed	that	it	would	also	make	other	pregnant	women	aware	that	










offer	 and	 a	 non‐reimbursed	 screening	 offer,	 might	 challenge	 the	
nondirectiveness	of	the	screening	offer	and	the	related	counseling,	
whereby	nondirective	means	‘withholding	any	normative	judgment	

























Some	 women	 were	 enthusiastic	 about	 an	 expansion	 because	
they	 thought	 that	 obtaining	more	 information	 is	 something	 good.	
Others,	however,	were	hesitant	toward	the	expansion	of	NIPT	and	
expressed	 the	 fear	 of	 a	 possible	 slippery	 slope.	 The	 interviewed	
pregnant	women	were	made	aware	of	the	existence	of	a	large	num‐
ber	of	serious	conditions	other	than	trisomies	21,	18,	and	13	through	
this	discussion,	and	some	of	 them	 linked	 this	 to	 their	own	unborn	










In	 the	 literature,	 to	 help	women	make	 individualized	 decisions	
about	 the	scope	of	prenatal	 screening,	 it	has	been	suggested	 that	
women	 should	 choose	 from	 a	menu	 of	 options	 (Bunnik,	 de	 Jong,	
Nijsingh,	&	de	Wert,	2013),	with	different	categories	of	conditions	
included	 in	 the	 screening	 offer.	 Also,	 in	 another	 interview	 study	
pregnant	women	 favored	 ‘pure	 choice’	model	 for	 expanded	NIPT,	
wherein	 reproductive	 autonomy	 and	 informed	 choice	 are	 used	 to	
justify	 any	 prenatal	 screening	 decision	 a	 women	 wants	 to	 make	
(Vanstone,	Cernat,	Nisker,	&	Schwartz,	2018).	According	to	the	find‐












ers,	 and	 ethicists	 (de	 Jong	 et	 al.,	 2013;	 Kater‐Kuipers,	 Bunnik,	 de	





the	 test	 results	 first,	 and	 only	 after	 something	 of	 relevance	 has	
been	found,	they	would	wish	to	learn	more	detailed	information	on	
the	 condition	 detected.	 These	 findings	 suggest	 that	 in	 case	 of	 an	
expanded	NIPT	women	might	prefer	a	 layered	counseling	wherein	
information	in	several	stages	can	be	provided	to	women	in	order	to	
prevent	 information	overload,	 as	 is	 proposed	 in	 a	 layered	 consent	




The	 strength	 of	 this	 study	 is	 that	 we	 included	 pregnant	 women	













pregnant	group	more	 than	half	 (11	out	of	19)	of	 the	 interviewed	
pregnant	women	opted	for	NIPT	or	 the	ftCT,	whereas	 in	 the	en‐
tire	Dutch	pregnant	population	 less	than	half	 (45%)	opts	for	 first	
trimester	screening.	Therefore,	the	interpretation	of	these	results	
must	be	performed	with	caution,	 as	 these	might	not	be	general‐
izable	 to	 the	entire	Dutch	pregnant	population.	Furthermore,	 al‐
though	 we	 actively	 sought	 other	 target	 groups,	 mostly	 Dutch,	
highly	educated,	nonreligious	women	participated,	which	may	also	
cause	 problems	 in	 the	 generalizability	 of	 the	 results.	 Also,	 some	
of	the	 interviews	were	conducted	before	the	availability	of	NIPT	
to	 all	 pregnant	women	 in	 the	Netherlands,	 whereas	 other	 inter‐
views	were	conducted	after	 its	 implementation,	which	may	have	
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5  | CONCLUSION
Our	study	shows	that	there	is	a	varying	and	broad	range	of	opin‐
ions	 about	 first	 trimester	 prenatal	 screening,	 NIPT,	 pressure	 to	
test,	 the	 reimbursement	 of	 screening	 and	 the	 expanding	 scope	
among	 pregnant	 women	 in	 the	 Netherlands.	 Women	 feel	 that	
they	have	a	free	choice	to	opt	for	or	decline	prenatal	screening,	
even	though	they	sometimes	receive	advice	from	others	for	their	
decision.	 Adequate	 pretest	 counseling	 is	 important	 to	 maintain	
this	experience	of	choice	liberty	now	that	NIPT	has	become	part	
of	 the	 screening	 offer.	 However,	 counseling	 might	 need	 a	 shift	
in	 focus	 toward	 deliberation	 about	 what	 women	want	 to	 know	
about	the	health	of	their	child	and	what	they	want	to	do	with	the	
results,	taking	into	account	personal	 informational	needs—which	
is	 already	 started	 in	 all	 Dutch	 training	 institutions	 and	midwife	
practices.	The	significance	of	pretest	counseling	for	first	trimester	
screening	 continues	 to	 be	 a	 factor	 of	 great	 attention.	However,	
our	 study	clearly	 shows	 two	 important	 social	 issues	 that	 should	
be	addressed	in	counseling.	First	of	all,	freedom	of	choice	should	
be	emphasized	and	 second,	possible	messages	deriving	 from	ei‐
ther	 reimbursed	 or	 nonreimbursed	 screening	 should	 be	 mini‐
mized.	 Most	 women	 felt	 that	 not	 fully	 reimbursing	 screening	
could	 prevent	 the	 routinization	 of	 NIPT,	 but	 that	 this	 may	 also	
cause	 unequal	 access	 to	 healthcare.	 Furthermore,	 women	 had	
difficulty	making	statements	about	expanding	the	scope	of	NIPT,	
but	 agreed	 that	 determining	 the	 scope	 should	 mainly	 be	 based	
on	severe,	 life‐threatening	disorders.	Finally,	our	results	suggest	
that	 the	scope	of	NIPT	should	be	determined	by	experts	 (in	 the	
Netherlands	these	could	include	midwives,	gynecologists,	clinical	
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